A clinical breakdown of spironolactone adverse events by severity grade and patient phenotype, including data from FAERS, randomized trials, and dermatology cohorts. Reviewed by board-certified physicians.
A guide to tadalafil's rare but potentially lasting adverse effects, including NAION, priapism, hearing loss, and serotonin interactions, with data from FDA labeling, FAERS, and published trials.
FDA found no human trials of TB-500, so no incidence rates exist. Here is what its adverse-event searches and related thymosin beta-4 trials show.
A clinical review of TB-500 (thymosin beta-4 active fragment) withdrawal and discontinuation syndrome, adverse events, and what to expect when stopping this research peptide.
A detailed clinical guide to delayed-onset side effects of tesamorelin (Egrifta), including fluid retention, glucose changes, injection-site reactions, and IGF-1 elevation, with trial data, FDA labeling, and post-market evidence.
A guide to the rare and serious adverse events associated with tesamorelin (Egrifta), including IGF-1 elevation, glucose dysregulation, malignancy risk, and injection-site reactions, with citations from trials and the FDA label.
A clinical review of delayed-onset side effects from Thymosin Alpha-1 (thymalfasin), covering immune-mediated reactions, post-market data, FAERS reports, and how to monitor for late adverse events.
A clinical review of Thymosin Alpha-1 (thymalfasin) side effects, adverse events, and what happens when the peptide is stopped, including FAERS data, trial evidence, and post-market literature.
A data-first review of topical minoxidil 5% adverse event rates from key trials, FAERS reports, and post-market literature, with clinical guidance on recognition and management.
A guide to the rare but serious adverse events associated with topical minoxidil 5%, covering systemic absorption, cardiovascular risks, FAERS data, and evidence-based monitoring protocols.
A complete clinical guide to delayed-onset side effects of tretinoin topical, including retinoid dermatitis, post-inflammatory hyperpigmentation, photosensitivity, and systemic absorption risks, with trial data and FDA label guidance.
A guide to tretinoin topical side effects, covering reversible irritation, rare persistent changes, and the evidence on potentially permanent skin alterations from long-term use.
Does tretinoin cause withdrawal symptoms when you stop? Learn what the FDA label, FAERS data, and clinical trials actually say about tretinoin discontinuation, rebound, and how to stop safely.
A detailed breakdown of vaginal estradiol adverse event rates from key clinical trials, FDA labeling, FAERS data, and post-market literature, prepared by the HealthRX.com Editorial Team.
A detailed breakdown of vardenafil adverse event rates from Phase III trials, FDA labeling, FAERS reports, and post-market literature, with dose-by-dose incidence data.
A data-driven breakdown of sildenafil (Viagra) adverse event rates drawn from key trials, FDA labeling, and post-market surveillance, with exact percentages, named studies, and clinical context.
A guide to the rare but serious adverse events linked to Viagra (sildenafil), including NAION, priapism, sudden hearing loss, and dangerous drug interactions, with primary-source citations throughout.
A clinically detailed guide to the rare but serious adverse events associated with Wegovy (semaglutide 2.4 mg), covering thyroid tumors, pancreatitis, gallbladder disease, kidney injury, suicidality, and more, with trial data and FDA label citations.
Specific dietary changes, hydration targets, meal-timing strategies, and evidence-backed supplements that reduce constipation caused by Wegovy (semaglutide 2.4 mg).
Wegovy 2.4 mg diarrhea occurred in 30% of adults versus 16% on placebo. The label says it delays gastric emptying but gives no diarrhea mechanism.
Food, fiber, fluids and movement for constipation during Zepbound treatment, with study details and practical ways to compare what you have tried.
A frank, evidence-anchored look at how common nausea actually is on Zepbound (tirzepatide), how severe it tends to be, who is most at risk, and what the trial data say about resolution timelines.
Concrete dietary, hydration, and meal-timing strategies to reduce vomiting on Zepbound (tirzepatide), grounded in trial data and GI physiology. For patients and prescribers managing this side effect right now.
Evidence-based supplements to reduce vomiting on Zepbound (tirzepatide), with clinical trial data, dosing, and a decision framework.
Evidence-based sildenafil dosing for patients aged 65+, including starting doses, titration steps, drug interaction risks, renal and hepatic adjustments, and deprescribing guidance prepared by the HealthRX.com Editorial Team.
A clinician-oriented review of sildenafil use in autoimmune conditions: pharmacology, drug interaction risk, dosing caution points, and the evidence boundaries around Raynaud phenomenon, connective-tissue-disease PAH, and proposed anti-inflammatory effects.
A guide to acne vulgaris, male and female pattern hair loss, telogen effluvium, and alopecia areata. Covers FDA-approved drugs, off-label options, evidence quality, and when to seek in-person care.
Evidence-based answers on collagen supplements for skin, oral and topical minoxidil for women, finasteride and PFS risk, and the real Accutane timeline. Written by the HealthRX.com medical team.
How to distinguish hirsutism, pattern hair loss, diffuse shedding and alopecia areata, with diagnosis-specific tests, treatments and follow-up.
4% hydroquinone cream lightens skin in 8 to 12 weeks. See dosing, the 3 to 6 month use limit, and how it compares to tretinoin and adapalene.
A guide to psoriasis covering pathophysiology, FDA-approved systemic and biologic therapies, and how psoriasis overlaps with scalp hair loss conditions including telogen effluvium and alopecia areata.
A guide to rosacea subtypes, male and female pattern hair loss, telogen effluvium, and alopecia areata. Includes FDA-approved treatments, dosing details, and clinical trial data.
A guide to prescription and evidence-based treatments for skin aging, hair loss, and medical aesthetics, including tretinoin, minoxidil, GHK-Cu peptides, PRP, and GLP-1 effects on skin quality.
Topical minoxidil is OTC for hair loss; needs daily use for 16+ weeks and ongoing use to keep results. See dosing, results, and how it compares to other topical Rx.
A detailed guide to CareFirst BlueCross BlueShield coverage for Dupixent (dupilumab), including prior authorization requirements, step therapy, appeal rights, and cost-saving options for atopic dermatitis, asthma, and other FDA-approved indications.
Find out whether Regence BlueCross BlueShield covers Dupixent (dupilumab) for atopic dermatitis, asthma, and other approved indications, including prior authorization steps, cost-sharing, and appeal strategies.
A step-by-step guide to layering skincare products in midlife, covering morning and evening routines, hormone-driven skin changes, and evidence-based ingredient choices.
A clinical deep-dive into whether topically applied estriol absorbs enough to raise serum estrogen levels, affect the endometrium, or require progestogen co-administration. Evidence-based.
CBT-I outperforms sleep medication long-term, with 70-80% of patients reaching normal sleep. Learn diagnosis criteria and when to rule out sleep apnea first.
A comparison of dual orexin receptor antagonists (suvorexant, lemborexant), Z-drugs (zolpidem, eszopiclone, zaleplon), trazodone, ramelteon, and melatonin for chronic insomnia. Covers efficacy data, abuse potential, next-day impairment, and who should get what.
A guide to eszopiclone (Lunesta): FDA-approved doses, mechanism of action, side effects, drug interactions, and head-to-head comparisons with zolpidem (Ambien), zaleplon (Sonata), suvorexant (Belsomra), and melatonin.
No trial shows magnesium glycinate improves sleep. One 8-week trial of 500 mg magnesium in 46 older adults found benefit, but reviews are mixed.
A clinical comparison of melatonin and ramelteon for insomnia, including dosing, mechanism, safety, and how they stack up against Ambien, Lunesta, trazodone, mirtazapine, Belsomra, and CPAP therapy.
A guide to using mirtazapine for sleep: how it works, what doses are used off-label, trial data, and a head-to-head comparison with zolpidem, eszopiclone, zaleplon, and melatonin.
PLMD treatment starts with dopamine agonists like pramipexole or ropinirole, plus iron repletion if ferritin is under 75 ng/mL. See diagnostic criteria.
Trazodone is not FDA-approved for insomnia. The label covers major depression in adults only, so sleep use is off-label.
Adults start at 25 to 50 mg daily, titrating to 50 to 100 mg for acne control. Max studied dose is 200 mg/day. Includes potassium monitoring schedule.
A clinical guide to spironolactone monitoring for adults aged 30 to 49 using it for hormonal acne or hirsutism, with context on cardiac and blood pressure uses. Covers lab schedules, potassium risks, blood pressure, drug interactions, and pregnancy precautions.
Evidence-based spironolactone dosing for adults aged 50, 64 treating hormonal acne, hirsutism, or heart failure. Covers starting doses, titration, perimenopause overlap, potassium monitoring, and drug interactions.
A week-by-week first-month spironolactone plan for acne, with practical tracking, dose review, testing guidance and results from SAFA and Mayo Clinic.
Mixing Adderall with energy drinks raises heart rate and blood pressure. Keep caffeine under 100mg per dose and monitor your pulse regularly.
What is actually known about combining glycine with Adderall XR (mixed amphetamine salts): pharmacokinetics, sleep effects, dosing timing, and where the evidence runs out.
The Adderall XR label does not name magnesium, but it says GI antacids and urinary alkalinizing agents raise amphetamine levels and should be avoided.
A guide to the vitamin D and Adderall XR interaction: pharmacokinetics, pharmacodynamics, dosing, monitoring, and safety for adults and children with ADHD.
Considering zinc with Adderall XR? Check age-specific intake limits, count zinc across products, and understand what the ADHD research can tell you.
A guide to the ashwagandha, alendronate interaction: pharmacokinetics, cortisol and thyroid effects, dose-separation strategy, and what to monitor if you take both.
A guide covering the pharmacokinetic and pharmacodynamic interaction between L-theanine and alendronate (Fosamax), including dose-separation rules, absorption risks, and monitoring recommendations.
Creatine and Praluent (alirocumab): no labeled interaction, and how creatine can raise serum creatinine on kidney blood tests.
A clinical review of the glutathione, alprostadil interaction: pharmacokinetics, oxidative-stress biology, safety signals, dosing timing, and monitoring for men using Caverject or MUSE.
A guide to the NAC and alprostadil interaction, covering pharmacokinetics, pharmacodynamics, dosing windows, monitoring, and safety for men using Caverject or MUSE.